Nvidia just gave its AI biology platform a brain upgrade. At the BIO International Convention on June 23, the company announced the BioNeMo Agent Toolkit, a new framework that pairs its existing BioNeMo platform with agentic AI capabilities designed to automate and accelerate biological research workflows.
The toolkit creates specialized agents capable of tool invocation, interpreting scientific results, and speeding up hypothesis generation. Instead of researchers manually querying models and piecing together outputs, these agents can chain together multiple steps of a discovery workflow on their own.
What the toolkit actually does
The BioNeMo Agent Toolkit sits at the intersection of two existing Nvidia ecosystems. On one side, you have BioNeMo, Nvidia’s platform for AI-driven biology that includes open models and microservices tailored for drug discovery. On the other, there’s the broader NeMo Agent Toolkit, which Nvidia originally introduced around March 2025 as a general framework for building production-grade AI agents.
Early adopters are already building on it. Simulations Plus, a company focused on modeling and simulation for pharmaceutical research, is among the first partners. HighRes, with its Cellario OS laboratory automation platform, is another. Both are integrating the toolkit into their existing workflows.
